Whittier Trust Co. of Nevada Inc. raised its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 23.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,215 shares of the biotechnology company's stock after buying an additional 1,925 shares during the period. Whittier Trust Co. of Nevada Inc.'s holdings in Axon Enterprise were worth $6,071,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Prestige Wealth Management Group LLC grew its position in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock valued at $33,000 after buying an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC acquired a new position in Axon Enterprise in the fourth quarter valued at $40,000. Brooklyn Investment Group acquired a new position in Axon Enterprise in the third quarter valued at $41,000. Y.D. More Investments Ltd purchased a new position in shares of Axon Enterprise during the fourth quarter worth about $45,000. Finally, Stonebridge Financial Group LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth about $53,000. 79.08% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of research firms recently issued reports on AXON. JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Barclays restated a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. Robert W. Baird upped their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. TD Cowen started coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a "buy" rating and a $700.00 price target for the company. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and lifted their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, Axon Enterprise currently has an average rating of "Moderate Buy" and an average target price of $604.67.
View Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Stock Performance
NASDAQ:AXON traded up $4.66 during mid-day trading on Tuesday, reaching $577.18. The stock had a trading volume of 439,520 shares, compared to its average volume of 835,219. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The business has a 50 day simple moving average of $591.92 and a 200 day simple moving average of $546.67. The firm has a market capitalization of $44.23 billion, a price-to-earnings ratio of 149.14, a PEG ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.
Insider Buying and Selling
In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jeri Williams sold 307 shares of the company's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by corporate insiders.
Axon Enterprise Company Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.